insights_auto
Perché CMXHF è in calo 3,91%?
Approfondiscichevron_right
CMXHF:OTCMKTS
CSL
121,10 USD
arrow_downward
-3,91%(-4,93) 1G
9 ott, 16:00:00 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per CMXHF in corso…
Apertura
121,10 USD
Massimo
121,10 USD
Minimo
121,10 USD
Cap. mercato
88,69 Mld
Vol. medio
151,00
Volume
0,00
Max 52 sett.
148,36 USD
Min 52 sett.
63,84 USD
Beta
0,56
Azioni in circolazione
479,88 Mln
N. di dipendenti
29K
Apertura
121,10 USD
Massimo
121,10 USD
Minimo
121,10 USD
Cap. mercato
88,69 Mld
Vol. medio
151,00
Volume
0,00
Max 52 sett.
148,36 USD
Min 52 sett.
63,84 USD
Beta
0,56
Azioni in circolazione
479,88 Mln
N. di dipendenti
29K
Articoli giornalistici
Da fonti web e partner giornalistici
ad-hoc-news.de
·
2 ore fa
CSL stock trades at EUR 114.24 with AUD 88.5 billion market cap
ad-hoc-news.de
·
7 ore fa
CSL signs rare-disease deal and CSL stock costs EUR 114.58
Profilo
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Informazioni su CSL
CEOPaul McKenzie
Dipendenti29K
Data di fondazione1916
SedeMelbourne, Victoria, Australia
Settore-
Sito webcsl.com